Patents by Inventor Nabajyoti Deka

Nabajyoti Deka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130040988
    Abstract: Compounds represented by the general formula (1): pharmaceutically acceptable salts or solvates thereof, a process for their manufacture; pharmaceutical compositions containing them; and use of the compounds in the treatment of metabolic disorders related to insulin resistance or hyperglycemia are described.
    Type: Application
    Filed: August 13, 2012
    Publication date: February 14, 2013
    Inventors: Nabajyoti DEKA, Kamlesh Jyotindra Padiya, Swapnil Ramesh Bajare, Rhushikesh Arun Kulkarni, Taj Usman Khan, Sivaramakrishnan Hariharan, Rosalind Adaikalasamy Marita
  • Patent number: 8349862
    Abstract: The present invention provides novel compounds represented by the general formula (I): their stereoisomers, pharmaceutically acceptable salts and their pharmaceutically acceptable solvates thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. The invention also relates to a process for the manufacture of compounds of formula (I) and pharmaceutical compositions containing them.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: January 8, 2013
    Assignee: Piramal Healthcare Limited
    Inventors: Nabajyoti Deka, Sivaramakrishnan Hariharan, Swapnil Ramesh Bajare, Rosalind Adaikalasamy Marita
  • Publication number: 20120309786
    Abstract: Compounds represented by the general formula (I): pharmaceutically acceptable salts or solvates thereof, a process for their manufacture; pharmaceutical compositions containing them; and use of the compounds in the treatment of metabolic disorders related to insulin resistance or hyperglycemia are described.
    Type: Application
    Filed: August 13, 2012
    Publication date: December 6, 2012
    Inventors: Nabajyoti DEKA, Kamlesh Jyotindra Padiya, Swapnil Ramesh Bajare, Rhushikesh Arun Kulkarni, Taj Usman Khan, Sivaramakrishnan Hariharan, Rosalind Adaikalasamy Marita
  • Patent number: 8269010
    Abstract: The present invention provides novel compounds represented by the general formula (I): their pharmaceutically acceptable salts and their pharmaceutically acceptable solvates thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. The invention also relates to a process for the manufacture of compounds of formula (I) and pharmaceutical compositions containing them.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: September 18, 2012
    Assignee: Piramal Healthcare Limited
    Inventors: Nabajyoti Deka, Kamlesh Jyotindra Padiya, Swapnil Ramesh Bajare, Rhushikesh Arun Kulkarni, Taj Usman Khan, Sivaramakrishnan Hariharan, Rosalind Adaikalasamy Marita
  • Publication number: 20110312970
    Abstract: The present invention provides novel compounds represented by the general formula (I): their stereoisomers, pharmaceutically acceptable salts and their pharmaceutically acceptable solvates thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. The invention also relates to a process for the manufacture of compounds of formula (I) and pharmaceutical compositions containing them.
    Type: Application
    Filed: August 31, 2011
    Publication date: December 22, 2011
    Applicant: PIRAMAL LIFE SCIENCES LIMITED
    Inventors: Nabajyoti DEKA, Sivaramakrishnan HARIHARAN, Swapnil Ramesh BAJARE, Rosalind Adaikalasamy MARITA
  • Patent number: 8030324
    Abstract: The present invention provides novel compounds represented by the general formula (I): their stereoisomers, pharmaceutically acceptable salts and their pharmaceutically acceptable solvates thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. The invention also relates to a process for the manufacture of compounds of formula (I) and pharmaceutical compositions containing them.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: October 4, 2011
    Assignee: Piramal Life Sciences Ltd.
    Inventors: Nabajyoti Deka, Sivaramakrishnan Hariharan, Swapnil Ramesh Bajare, Rosalind Adaikalasamy Marita
  • Publication number: 20100022554
    Abstract: The present invention provides novel compounds represented by the general formula (I): their stereoisomers, pharmaceutically acceptable salts and their pharmaceutically acceptable solvates thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. The invention also relates to a process for the manufacture of compounds of formula (I) and pharmaceutical compositions containing them.
    Type: Application
    Filed: September 20, 2007
    Publication date: January 28, 2010
    Inventors: Nabajyoti Deka, Sivaramakrishnan Hariharan, Swapnil Ramesh Bajare, Rosalind Adaikalasamy Marita
  • Publication number: 20090318465
    Abstract: The present invention relates to a method for identifying compounds that act as insulin-sensitizers. The method can include screening of test compounds in two assays of insulin sensitivity. This method can identify lead compounds for the treatment of disorders caused by insulin resistance to glucose uptake. This invention also includes methods for treating insulin resistance and related disorders.
    Type: Application
    Filed: September 20, 2007
    Publication date: December 24, 2009
    Inventors: Rosalind Adaikalasamy Marita, Somesh Sharma, Jessy Anthony, Kelkar Aditya, Sujit Kaur Bhumra, Aditee Ghate, Kumar Venkata Subrahman Nemmani, Nabajyoti Deka, Ashok Kumar Gangopadhyay
  • Publication number: 20090247574
    Abstract: The present invention provides novel compounds represented by the general formula (I): their pharmaceutically acceptable salts and their pharmaceutically acceptable solvates thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. The invention also relates to a process for the manufacture of compounds of formula (I) and pharmaceutical compositions containing them.
    Type: Application
    Filed: September 20, 2007
    Publication date: October 1, 2009
    Inventors: Nabajyoti Deka, Kamlesh Jyotindra Padiya, Swapnil Ramesh Bajare, Rhushikesh Arun Kulkarni, Taj Usman Khan, Sivaramakrishnan Hariharan, Rosalind Adaikalasamy Marita